TGTX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TGTX shares is 410, representing 67.17% of the company's common stock.

SIMPLEX TRADING, LLC, in the last quarter, reduced its stake in TGTX by -12.8% restricting it's holding to 189.85 thousand shares of worth nearly $2.89M. M28 CAPITAL MANAGEMENT LP also lessened -25.39% of the TGTX shares from its portfolio, reducing its holding to 161.6 thousand shares of worth $2.46M. RHENMAN & PARTNERS ASSET MANAGEMENT AB also shunned TGTX shares holding by -22.81% last quarter which brought its holding to 123.5 thousand shares worth $1.88M.

As per its latest 13F filing, SWISS NATIONAL BANK increased its stake in TGTX by 0.53% in the last quarter. The institutional holder raised its holding to 284.1 thousand shares having worth more than $4.32M. CREDIT SUISSE AG/ also added 0.41% more shares of TGTX to its portfolio, raising its holding to 186.3 thousand shares of worth $2.83M. HENNION & WALSH ASSET MANAGEMENT, INC. also increased its TGTX shares holding by 16.93% which brought its holding to 184.82 thousand shares worth $2.81M.

The insider with the most stakes in TGTX is RA CAPITAL MANAGEMENT, L.P. , 10 percent owner at the company. Additionally, TGTX stock is highly held by CEO and President WEISS MICHAEL S and 10 percent owner LFB Biotechnologies S.A.S.U. among others.

Company executives, directors, and other insiders own 9.81% percent of TG Therapeutics, Inc.'s stock. Within the last six months, there have been 5 transaction(s) in which TGTX insiders have sold stock, totaling 71.36K shares. Insiders that have sold shares include POWER SEAN A, CHARNEY LAURENCE N, and LONIAL SAGAR.

There have been 0 transaction(s) during the past 6-months in which TG Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 1.87M TG Therapeutics, Inc. shares are held by insiders, which represents about 9.81% of TGTX stock.

TGTX 10 percent owner, RA CAPITAL MANAGEMENT, L.P. holds the largest portfolio of the company's shares. TGTX shares owned by RA total nearly 12.63 million.

SWISS NATIONAL BANK is the largest institutional owner in TGTX which holds 284.1 thousand shares worth $4.32M or 0.2% of the total TGTX shares outstanding followed by SIMPLEX TRADING, LLC with ownership of 189.85 thousand shares representing 0.13% of the TGTX ownership. CREDIT SUISSE AG/ is the third largest stakeholder with 186.3 thousand shares or 0.13% of the ownership worth more than $2.83M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TGTX is concerned, it is a stock which is optionable.

Number of TGTX shares short is 26.88M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 155.66M shares of TGTX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TGTX has 132.76M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TGTX is 10.16.